COVID-19 Drug Associated APIs Global Market Report 2023

Feb 2023| TBR1057D| TBRC (Publisher)

Sample Report

Report Highlights

Including: 1) By Drug Class: Antimalarials; Bronchodilators; Antibiotics; Antivirals
2) By Synthesis Type: Synthetic; Biotech
3) By Business Mode: Captive API; Merchant API
Covering: Dr. Reddy's Laboratories; Lianyungang Guike Pharmaceutical; Alembic Pharmaceutical; Wockhardt Ltd.; Sandoz Srl

COVID-19 Drug Associated APIs Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on covid-19 drug associated apis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:
Where is the largest and fastest growing market for covid-19 drug associated apis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The covid-19 drug associated apis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Report Synopsis

Report Metrics	Details
Base year considered	2022
Forecast period considered	2022-2032
Units considered	$ Billion
Segments covered	By Drug Class, By Synthesis Type, By Business Mode
Industry covered	Pharmaceuticals
Regions covered	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Countries covered	Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
Companies studied	Dr. Reddy's Laboratories Aspiro Pharma Lianyungang Guike Pharmaceutical Alembic Pharmaceutical Wockhardt Ltd. Sandoz Srl Lupin Limited Aurobindo Pharma Ltd. Shanghai Shyndec Pharmaceutical (Haimen) Co. Ltd. Yatai Pharma Zhejiang Guobang Pharmaceutical Co. Ltd. Cipla Shandong Boyuan Pharmaceutical Shenzhen China Resources Gosun Pharmaceutical Co. Ltd. Qilu Antibiotics Pharmaceutical Co. Ltd. Wallace Pharma Zhejiang Cheng Yi Pharmaceutical Star Lake Bioscience Co. Inc. Hetero Labs Geno Pharmaceuticals Mylan Laboratories IPCA Labs Zydus Takeda Mangalam Drugs & Organics

Scope

Markets Covered:

By Drug Class: Antimalarials; Bronchodilators; Antibiotics; Antivirals; Other Drug Class
By Synthesis Type: Synthetic; Biotech
By Business Mode: Captive API; Merchant API

Companies Mentioned: Dr. Reddy's Laboratories; Lianyungang Guike Pharmaceutical; Alembic Pharmaceutical; Wockhardt Ltd; Sandoz Srl

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Table 1 : Global Historic Market Growth, 2017-2022, $ Billion
Table 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Table 3 : Global COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 4 : Asia-Pacific, COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 5 : Asia-Pacific, COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 6 : Global COVID-19 Drug Associated APIs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 7 : Global COVID-19 Drug Associated APIs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 8 : Asia-Pacific, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 9 : China, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 10 : India, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 11 : Japan, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 12 : Australia, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 13 : Indonesia, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 14 : South Korea, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 15 : Western Europe, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 16 : UK, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 17 : Germany, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 18 : France, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 19 : Eastern Europe, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 20 : Russia, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 21 : North America, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 22 : USA, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 23 : South America, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 24 : Brazil, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 25 : Middle East, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 26 : Africa, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 27 : Dr. Reddy's Laboratories Financial Performance
Table 28 : Lianyungang Guike Pharmaceutical Financial Performance
Table 29 : Alembic Pharmaceutical Financial Performance
Table 30 : Wockhardt Ltd Financial Performance
Table 31 : Sandoz Srl Financial Performance

Figure 1 : Global Historic Market Growth, 2017-2022, $ Billion
Figure 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Figure 3 : Global COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 4 : Asia-Pacific, COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 5 : Asia-Pacific, COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 6 : Global COVID-19 Drug Associated APIs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 7 : Global COVID-19 Drug Associated APIs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 8 : Asia-Pacific, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 9 : China, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 10 : India, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 11 : Japan, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 12 : Australia, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 13 : Indonesia, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 14 : South Korea, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 15 : Western Europe, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 16 : UK, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 17 : Germany, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 18 : France, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 19 : Eastern Europe, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 20 : Russia, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 21 : North America, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 22 : USA, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 23 : South America, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 24 : Brazil, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 25 : Middle East, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 26 : Africa, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 27 : Dr. Reddy's Laboratories Financial Performance
Figure 28 : Lianyungang Guike Pharmaceutical Financial Performance
Figure 29 : Alembic Pharmaceutical Financial Performance
Figure 30 : Wockhardt Ltd Financial Performance
Figure 31 : Sandoz Srl Financial Performance

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

COVID-19 Drug Associated APIs Global Market Report 2022

Published Date - Mar 2022
Report Code - TBR1057C

Including: 1) By Drug Class: Antimalarials; Bronchodilators; Antibiotics; Antivirals; Others
2) By Synthesis Type: Synthetic; Biotech
3) By Business Mode: Captive API; Merchant API
Covering: Dr. Reddy's Laboratories; Lianyungang Guike Pharmaceutical; Alembic Pharmaceutical; Wockhardt Ltd.; Sandoz Srl

COVID-19 Drug Associated APIs Global Market Report 2022 from The Business Research Company provides the strategists, marketers and senior management with the critical ...

COVID-19 Drug Associated APIs Global Market Report 2021: COVID-19 Growth And Change To 2030

Published Date - Sep 2021
Report Code - TBR1057B

Including: 1) By Drug Class: Antimalarials; Bronchodilators; Antibiotics; Antivirals; Others
Covering: Dr. Reddy's Laboratories; Lianyungang Guike Pharmaceutical; Alembic Pharmaceutical; Wockhardt Ltd; Sandoz Srl

COVID-19 Drug Associated APIs Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global ...

COVID-19 Drug Associated APIs Global Market Report 2020: COVID 19 Growth and Change

Published Date - Jul 2020
Report Code - TBR1057A

Including:

By Drug Class: Antimalarials; Bronchodilators; Antibiotics; Antivirals; Others

Covering: Dr. Reddy's Laboratories; Lianyungang Guike Pharmaceutical; Alembic Pharmaceutical; Wockhardt Ltd; Sandoz Srl

COVID-19 Drug Associated APIs Global Market Report 2020: COVID 19 Growth and Change from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global covid19 drug associated ...